| __timestamp | Johnson & Johnson | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 19586000 |
| Thursday, January 1, 2015 | 9046000000 | 29135000 |
| Friday, January 1, 2016 | 9095000000 | 42791000 |
| Sunday, January 1, 2017 | 10554000000 | 49577000 |
| Monday, January 1, 2018 | 10775000000 | 89209000 |
| Tuesday, January 1, 2019 | 11355000000 | 69099000 |
| Wednesday, January 1, 2020 | 12340000000 | 75961000 |
| Friday, January 1, 2021 | 14277000000 | 90467000 |
| Saturday, January 1, 2022 | 14135000000 | 74552000 |
| Sunday, January 1, 2023 | 15048000000 | 91593000 |
| Monday, January 1, 2024 | 17232000000 |
Data in motion
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Johnson & Johnson and Supernus Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Johnson & Johnson consistently allocated a significant portion of its resources to R&D, with expenditures growing by approximately 77%, reaching a peak in 2023. In contrast, Supernus Pharmaceuticals, Inc. showed a more modest increase of around 368% over the same period, reflecting its strategic focus on targeted innovation. While Johnson & Johnson's R&D spending dwarfs that of Supernus, the latter's growth rate highlights its dynamic approach in a competitive market. This comparison underscores the diverse strategies companies employ to drive innovation and maintain a competitive edge in the pharmaceutical industry.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Biogen Inc.
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Sanofi and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Veracyte, Inc. or Supernus Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.